Table 5 |
|||
|
Overall costs (€, 2003 price level) of the intensive care unit stay per patient |
|||
|
Remifentanil/propofol (n = 39) |
Midazolam/fentanyl (n = 33) |
P valuea |
|
|
|
|||
|
Material |
11/10 (5–25) |
11/11 (4–18) |
NS |
|
Non-study drugs |
218/137 (31–1257) |
192/153 (55–723) |
NS |
|
Study drugs |
353/341 (54–835) |
42/46 (19–63) |
<0.05 |
|
Nurses |
869/827 (517–2213) |
1,131/1,071 (554–2,164) |
<0.05 |
|
Physicians |
260/243 (135–723) |
352/301 (151–811) |
<0.05 |
|
Overall |
1,712/1,558 (1,058–3,647) |
1,729/1,604 (821–3,337) |
NS |
|
|
|||
|
Values are means/medians (range). aWilcoxon rank-sum test. NS, not significant. |
|||
|
Muellejans et al. Critical Care 2006 10:R91 doi:10.1186/cc4939 |
|||
